Showing results (21-30 of 55) with videos related to
Sort By:
Pageof 6
Journal of Urban Health : Bulletin of the New York Academy of Medicine|October 11, 2007
Access to multilingual medication instructions at New York City pharmaciesLinda Weiss, Francesca Gany, Peri Rosenfeld, et al.American Journal of Clinical Oncology|May 11, 2011
Management of single malignant lung nodules in elderly patients (70 years or older) who are not candidates for lobectomyBhupesh Parashar, Priti Patel, Prabhsimranjot Singh, et al.Cancer|July 24, 2010
Limited resection followed by intraoperative seed implantation is comparable to stereotactic body radiotherapy for solitary lung cancerBhupesh Parashar, Priti Patel, Stefano Monni, et al.Molecular Therapy : the Journal of the American Society of Gene Therapy|July 26, 2012
Balloon catheter delivery of helper-dependent adenoviral vector results in sustained, therapeutic hFIX expression in rhesus macaquesNicola Brunetti-Pierri, Aimee Liou, Priti Patel, et al.Asian Pacific Journal of Cancer Prevention : APJCP|July 28, 2023
Single Nucleotide Polymorphisms in Cytokine Genes are Associated with the Susceptibility to Oral Squamous Cell CarcinomaRitu Pandey, Rajeev Nema, Supriya Vishwakarma, et al.Public Health Reports (Washington, D.C. : 1974)|February 12, 2024
Hepatitis C Virus Testing, Infection, and Cases Reported Through Public Health Surveillance During Expanded Screening Recommendations, United States, 2013-2021Kathleen N Ly, Justin K Niles, Ruth B Jiles, et al.The Breast Journal|October 10, 2013
Assessment of pain as a sequela in patients treated with intracavitary brachytherapy accelerated partial breast irradiation (IBAPBI): preliminary results of a prospective studyEleni A Greenwood, Shana Coplowitz, Priti Patel, et al.Neuro-Oncology|January 18, 2020
Fyn tyrosine kinase, a downstream target of receptor tyrosine kinases, modulates antiglioma immune responsesAndrea Comba, Patrick J Dunn, Anna E Argento, et al.British Journal of Clinical Pharmacology|September 17, 2021
Exposure-response analysis of acalabrutinib and its active metabolite, ACP-5862, in patients with B-cell malignanciesHelena Edlund, Núria Buil-Bruna, Karthick Vishwanathan, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 15, 2020
Pharmacodynamic Analysis of BTK Inhibition in Patients with Chronic Lymphocytic Leukemia Treated with AcalabrutinibAnfal Alsadhan, Jean Cheung, Michael Gulrajani, et al.Pageof 6